JNJ

JOHNSON & JOHNSON

Tremor tracks 84 of its cancer trials. This is a large company with many drugs, so one trial matters less to it, and company-wide signals count for half.

Company-wide warning signs

These add points to every one of this company's trials.

4 insiders sold shares within a monthSince Aug 17, 2026+2

Trials

Key executives leaving

From the last 12 months of the company's SEC reports.

None found.

Insider trades (last 6 months)

“Insiders” are executives, board members, and big shareholders. Many of their sales are pre-planned: scheduled months ahead under a legal plan (called 10b5-1), so they usually say little. Tremor only counts sales that weren't pre-planned.

11 sales (11 not pre-planned) · 0 purchases

Schmid TimothyEVP, WW Chair, MedTech · Sep 2, 2026Sold 11,070 sharesabout $3.0 million · not pre-planned
Schmid TimothyEVP, WW Chair, MedTech · Sep 2, 2026Sold 22,527 sharesabout $6.2 million · not pre-planned
Taubert Jennifer LEVP, WWC. Innovative Medicine · Aug 17, 2026Sold 15,000 sharesabout $4.0 million · not pre-planned
Duato JoaquinCEO and Chairman of the Board · Aug 13, 2026Sold 20,976 sharesabout $5.5 million · not pre-planned
Duato JoaquinCEO and Chairman of the Board · Aug 13, 2026Sold 102,315 sharesabout $26.7 million · not pre-planned
Forminard Elizabeth

Recent SEC filings

Public companies must report important news and their finances to the SEC, the US agency that oversees the stock market.

Money left

Coming soon: how many months of cash the company has, from its quarterly reports.